-
Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.
Markasz L, Stuber G, Flaberg E, Jernberg AG, Eksborg S, Olah E, Skribek H, Szekely L.
BMC Cancer. 2006 Nov 13; 6:265. Epub 2006 Nov 13.
[BMC Cancer. 2006]
-
High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens.
Peres E, Savasan S, Klein J, Abidi M, Dansey R, Abella E.
J Clin Microbiol. 2005 Jul; 43(7):3540-3.
[J Clin Microbiol. 2005]
-
Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.
Gärtner BC, Schäfer H, Marggraff K, Eisele G, Schäfer M, Dilloo D, Roemer K, Laws HJ, Sester M, Sester U, et al.
J Clin Microbiol. 2002 Feb; 40(2):351-8.
[J Clin Microbiol. 2002]
- » See all...